Abstract
Although an inhibitor of the bacterial lipopolysaccharide biosynthesis, the title compound 2-deoxy-β-KDO (1) cannot pass through the bacterial membrane. The coupling of the carboxy function with peptidic carriers creates conjugates (prodrugs) like 2, which can be actively transported into the cell. Their stability in vivo can be modulated by modifying the potential cleavage sites.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Angewandte Chemie International Edition in English
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
